Thrombotic Thrombocytopenic Purpura in HIV-Infected Patients

Infectious Diseases in Clinical Practice

Volumn 12, Issue 2, 2004, Pages 99-106

  Blazes, David L ^a   Decker, Catherine F ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; COTRIMOXAZOLE; DAPSONE; IMMUNOGLOBULIN; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISONE; STEROID; VINCRISTINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LYMPHOCYTE COUNT; MALE; OPPORTUNISTIC INFECTION; PLASMAPHERESIS; PROGNOSIS; RELAPSE; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 1642337033     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000121025.62151.80     Document Type: Article

References (60)

1. Kaplan BS. Thrombotic microgangiopathy: a proposal for a new terminology for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. J Nephrol 1995;8:3-4.
2. Hymes KB, Karpatkin S. Human immunodeficiency virus infection and thrombotic microaniopathy. Semin Hematology. 1997 Apr;34(2):117-125.
3. Glatt AE, Anand A. Thrombocytopenia in patients infected with the human immunodeficiency virus: treatment update. Clin Infect Dis. 1995;21:415-423.
4. Leaf AN, Laubenstein LJ, Raphael B, et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med. 1991;109:194-197.
5. Ucar A, Fernandez HF, Byrnes JJ, et al. Thrombotic microangiopathy and retroviral infections: a 13-year experience. Am J Hematol. 1994;45:304-309.
6. Chu QD, Medeiros LJ, Fisher AE, et al. Thrombotic thrombocytopenic purpura and HIV infection. S Med J. 1995;88:82-86.
7. Jokela J, Flynn T, Henry K. Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)-seropositive homosexual man. Am J Hematol. 1987;25:341-343.
8. Rarick MU, Espina B, Mocharnuk R, et al. Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: a report of three cases and review of the literature. Am J Hematol. 1992;40:103-109.
9. Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenia purpura in the United States analysis of national mortality data, 1968-1991. Am J Hematol. 1995;50:84-90.
10. Yospur LS, Sun NC, Figueroa P, et al. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: case report and review of the literature. Am J Hematol. 1996;51:73-78.
11. Bell WR, Chulay JD, Feinberg JE. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204). Medicine. 1997;76:369-380.
12. Kwaan HC. Miscellaneous secondary thrombotic microangiopathy. Semin Hematol. 1987;24:141-147.
13. Peraldi MN, Maslo C, Desenclos JC, et al. Association between cytomegalovirus (CMV) infection and thrombotic microangiopathy (TMA) in HIV infected patients. J Am Soc Nephrol. 1995;6:473.
14. Remuzzi G. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: variable expression of a single entity. Kidney Int. 1987;32:292.
15. Boccia RV, Gelmann EP, Baker CC, et al. A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med. 1984;101:716-717.
16. delArco A, Martinez MA, Pena JM, et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells. Clin Infect Dis. 1993;17:360-363.
17. Avery RA, Denunzio TM, Craig DB. Thrombotic thrombocytopenic purpura associated with HIV and visceral Kaposi's sarcoma treated plasmapheresis and chemotherapy. Am J Hematol. 1998;58:148-149.
18. Thompson CE, Damon LE, Ries CA, et al. Thrombotic microangiopathies in the 1980's: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992;80:1890-1895.
19. Ripamonti D, Gregis G, Casari S, et al. Prevalence of thrombotic microangiopathy in a cohort of HIV infected patients. In: 11th International Conference on AIDS, 7-12 July 1996, Vancouver.
20. Gore I. Disseminated arteriolar and capillary platelet thrombosis: a morphological study of its histogenesis. Am J Pathol. 1987;26:155-175.
21. Kwann HC. Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin HematoL 1987;24:71-74.
22. Moake JL. The role of von Willebrand factor (vWF) in thrombotic thromboctyopenic purpura (IIP) and the hemolytic-uremic (HUS). Prog Clin Biol Res. 1990;337:135-140.
23. Sahud MA, Claster S, Liu L, et al. Von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Br J Haematol. 2002;116:909-911.
24. van de Kar NC, Sauerwein RW, Demacker PN, et al. Plasma cytokine levels in hemolytic uremic syndrome. Nephron. 1995;71:309-313.
25. Wada H, Kaneko T, Ohiwa M, et al. Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol. 1992;40:167-170.
26. Siddiqui FA, Lian EC. Characterization of platelet aggultinating protein p37 purified from the plasma of a patient with thrombotic thrombocytopenic purpura. Biochem Mol Biol Int. 1993;30:385-395.
27. Van Dam-Mieras MCE, Bruggemann CA, Muller AD, et al. Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thrombosis Res. 1987;47:69-75.
28. van Geelen AG, Slobbe-van Drunen ME, Muller AD, et al. Membrane related effects in endothelial cells induced by human cytomegalovirus. Arch Virol 1995;140:1601-1612.
29. Ridolfi RL, Bell WR. Thrombotic thrombocytopenia purpura. Report of 25 cases and review of the literature. Medicine (Baltimore). 1981;60:413-428.
30. Crucuu V, Parisio E, Pedretti D, et al. HIV-related thrombotic thrombocytopenic purpura (TTP) as first clinical manifestation of infection. Haematologica. 1994;79:277-279.
31. Nair JM, Bellevue R, Bertoni M, et al. Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS)-related complex. A report of two cases. Ann Intern Med. 1988;109;209-212.
32. Veenstra J, van der Lelie J, Mulder JW, et al. Low grade thrombotic thrombocytopenic purpura associated with HIV-1 infection. Br J Haematol. 1993;83:346-347.
33. Chaisson RE, Keruly JC, Moore RD. Incidence of a TTP-HUS-like syndrome in patients hospitalized with AIDS. In: 5th Conference of retroviruses and opportunistic infections, 1-5 February 1998, Chicago [Abstract no. 503].
34. Badesha PS, Saklayen MG. Hemolytic uremic syndrome as a presenting form of HIV infection. Nephron. 1996;72:472-475.
35. Beris P, Dunand V, Isoz C, et al. Association of thrombotic thrombocytopenic purpura and human immunodeficiency virus infection. Nouv Rev Fr Hematol. 1990;32:277-280.
36. deMan AM, Smulders YM, Roozendaal KJ, et al. HIV-related thrombotic thrombocytopenic purpura: report of 2 cases and a review of the literature. Neth J Med. 1997;51(3):103-109.
37. Esforzado N, Poch E, Almirall J, et al. Hemolytic uremic syndrome associated with HIV infection. AIDS. 1991;5:1041-1042.
38. Gadallah MF, el-Shahawy MA, Campese VM, et al. Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. Am J Nephrol. 1996;16(5):446-450.
39. Mayo J, Collazos J, Martinez J. Thrombotic microangiopathy related to infection in an HIV-positive patient. Eur J Clin Microbiol Infect Dis. 1996;15:254-256.
40. Melton RC, Spaide RF. Visual problems as a presenting sign of thrombotic thrombocytopenia purpura. Retina. 1996;16(1):78-80.
41. Nosari AM, Landonio G, Caggese L, et al. Thrombotic thrombocytopenic purpura associated with HIV infection: report of two cases. Haematologica. 1994;79:280-282.
42. Routy JP, Beaulieu R, Monte M, et al. Immunologic thrombocytopenia followed by thrombotic thrombocytopenic purpura in two HIV1 patients. Am J Hematol. 1991;38:327-328.
43. Salem G, Terebelo H, Raman S. Human immunodeficiency virus associated with thrombotic thrombocytopenic purpura: successful treatment with zidovudine. S Med J. 1991;84:493-495.
44. Shivaram U, Cash M. Purpura fulminans, metastatic endophthalmitis, and thrombotic thrombocytopenic purpura in an HIV-infected patient. NY State J Med. 1992;92:313-314.
45. Sutor GC, Schmidt RE, Albrecht H. Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature. Infection. 1999;27:12-14.
46. Karpatikin S. HIV-1 related thrombocytopenia. Baillieres Clin Haematol. 1990;3:115-138.
47. Bell WR, Braine HG, Ness PM, et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med. 1991;325:398-403.
48. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325:393-397.
49. Myers TJ, Wakem CJ, Ball ED, et al. Thrombotic thromboctyopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med. 1980;92:149-155.
50. del Zoppo GJ. Antiplatelet therapy in thrombotic thromboctyopenic purpura. Semin Hematol. 1987;24:130-139.
51. Rosove MH, Ho WG, Goldfinger D. Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura. Ann Intern Med. 1982;96:27-33.
52. Gutterman LA, Stevenson TD. Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA. 1982;247:1433-1436.
53. Levin M, Grunwald HW. Use of vincristine in refractory thrombotic thrombocytopenic purpura. Acta Haematol. 1991;85:37-40.
54. Ozsoylu S. Intravenous high dose methylprednisolone for thrombotic thrombocytopenic purpura [letter]. Am J Hematol. 1988;28:128.
55. Cuttner J. Thrombotic thrombocytopenia purpura: a ten-year experience. Blood. 1980;56:302-306.
56. Onundarson PT, Rowe JM, Heal JM, et al. Response to plasma exhange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution. Arch Intern Med. 1992;152:791-796.
57. Wells AD, Majumdar G, Slater NGP, et al. Role of splenectomy as salvage procedure in thrombotic thrombocytopenic purpura. Br J Surg. 1991;78:1389-1390.
58. Rose M, Rowe JM. The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Rev. 1993;7:94-103.
59. Shepard KV, Bukowski RM. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions and plasma exchange. Semin Hematol. 1987;24:178-193.
60. Meisenberg BR, Robinson WL, Mosley CA, et al. Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive males. Am J Hematol. 1988;27:212-225.